Analyst Stock Recommendations For Coupa Software Incorporated (COUP), Thermo Fisher Scientific Inc. (TMO)

Coupa Software Incorporated (NASDAQ:COUP) tinted gains of +1.73% (+1.63 points) to US$95.82. The volume of 1.65 Million shares climbed up over an trading activity of 1.38 Million shares. EPS ratio determined by looking at last 12 month figures is -0.85. Over the same time span, the stock marked US$97.07 as its best level and the lowest price reached was US$43.6. The corporation has a market cap of US$5.55 Billion.

Coupa Software Incorporated (NASDAQ:COUP)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -18.1 percent while most common profitability ratio return on investment (ROI) was -11.6 percent. The company’s institutional ownership is monitored at 0 percent. The company’s net profit margin has achieved the current level of -19.9 percent and possesses 68.7 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 7 think it is Hold. Recently, analysts have updated the overall rating to 2.33. 6 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

Thermo Fisher Scientific Inc. (NYSE:TMO) is worth US$106.15 Billion and has recently risen 1.73% to US$264.06. The latest exchange of 1.43 Million shares is below its average trading activity of 1.85 Million shares. The day began at US$261 but the price moved to US$259.69 at one point during the trading and finally capitulating to a session high of US$264.45. The stock tapped a 52-week high of US$260.11 while the mean 12-month price target for the shares is US$269.75.

Currently, the stock carries a price to earnings ratio of 36.46, a price to book ratio of 3.95, and a price to sales ratio of 4.36. For the past 5 years, the company’s revenue has grown 10.8%, while the company’s earnings per share has grown 12.2%. With an institutional ownership near 90.2%, it carries an earnings per share ratio of 7.24.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 10 brokerage firms polled by Factset Research. At present, 3 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 5 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.61.